throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`ACTAVIS, INC., ACTAVIS LABORATORIES FL, INC.,
`ACTAVIS PHARMA, INC., AMNEAL PHARMACEUTICALS, LLC,
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC.,
`BRECKENRIDGE PHARMACEUTICAL, INC., VENNOOT
`PHARMACEUTICALS, LLC, SANDOZ INC., SUN PHARMA GLOBAL FZE,
`and SUN PHARMACEUTICAL INDUSTRIES, LTD.,
`Petitioners
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner
`
`
`
`Case: IPR2014-01126
`Patent RE 38,551
`
`
`
`PETITIONERS’ EXHIBIT LIST
`(as of August 19, 2014)
`
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`P.O. Box 1450
`Alexandria, Virginia 22313–1450
`Submitted Electronically via the Patent Review Processing System
`
`

`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioners Actavis, Inc., Actavis
`
`Laboratories FL, Inc. (f/k/a Watson Laboratories, Inc. – Florida), Actavis Pharma,
`
`Inc. (f/k/a Watson Pharma, Inc.), Amneal Pharmaceuticals, LLC, Amneal
`
`Pharmaceuticals of New York, LLC, Aurobindo Pharma Ltd., Aurobindo Pharma
`
`USA, Inc., Breckenridge Pharmaceutical, Inc., Vennoot Pharmaceuticals, LLC,
`
`Sandoz Inc., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Ltd.
`
`submit the following Exhibit List identifying the exhibit number and a brief
`
`description of each exhibit filed in connection with the above-captioned petition
`
`for inter partes review.
`
`EXHIBITS
`
`Description
`
`U.S. Patent No. RE 38,551 to Kohn (“’551 patent”)
`(reissue of U.S. Patent No. 5,773,475 (“’475 patent”))
`
`Declaration of Clayton H. Heathcock, Ph.D.
`
`U.S. Patent No. 5,654,301 to Kohn and Watson
`(“’301 patent”)
`
`Jan. 28, 1998 Notice of Allowability
`(excerpt from prosecution history of ’475 patent)
`
`Philippe LeGall, 2-Substituted-2-acetamido-N-
`benzylacetamides. Synthesis, Spectroscopic and
`Anticonvulsant Properties (Dec. 1987) (“LeGall thesis”)
`
`Apr. 10, 1998 Amendment Under 37 C.F.R. § 1.312
`(excerpt from prosecution history of ’475 patent)
`
`
`
`Exhibit
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`
`
`

`
`
`
`Exhibit
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`1016
`
`Description
`
`Dec. 23, 2008 Application for Extension of Patent Term
`Under 35 U.S.C. § 156
`(excerpt from prosecution history of ’301 patent)
`
`U.S. Patent No. 5,378,729 to Kohn and Watson
`(“’729 patent”)
`
`Sergio Cortes et al., Effect of Structural Modification of the
`Hydantoin Ring on Anticonvulsant Activity, 28 J. Med.
`Chem. 601 (1985) (“Cortes”)
`
`Harold Kohn et al., Preparation and Anticonvulsant Activity
`of a Series of Functionalized α-Heteroatom-Substituted
`Amino Acids, 34 J. Med. Chem. 2444 (1991) (“Kohn 1991”)
`
`U.S. Food and Drug Administration, Approved Drug
`Products With Therapeutic Equivalence Evaluations 3-202,
`ADA 101 (34th ed. 2014) (“Orange Book”)
`
`U.S. Provisional Patent Application No. 60/013,522
`(“’522 prov. app.”)
`
`Apr. 14, 2014 Plaintiffs’ Response to Defendants’ Joint Set
`of Interrogatories (UCB, Inc., et al. v. Accord Healthcare,
`Inc., et al., C.A. No. 13-1206-LPS (D. Del.))
`
`Phillipe LeGall et al., Synthesis of Functionalized Non-
`Natural Amino Acid Derivatives via Amidoalkylation
`Transformations, 32 Int’l J. Peptide Protein Res. 279 (1988)
`
`R. L. M. Synge, CCXXXIX. Experiments On Amino Acids.
`IV. The Methyl Ethers Of Some N-Acetyl-Hydroxyamino-
`Acids, 33 Biochem. J. 1931 (1939)
`
`M. Jaeger et al., Enzymatic Resolution of O-Methyl-N-
`acetyl-DL-serine. Amino Acids. XXXII., 28 Croat. Chem.
`Acta 5 (1956)
`
`2
`
`

`
`
`
`Exhibit
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`Description
`
`Judith D. Conley & Harold Kohn, Functionalized DL-
`Amino Acid Derivatives. Potent New Agents for the
`Treatment of Epilepsy, 30 J. Med. Chem. 567 (1987)
`
`Judith D. Conley, Functionalized Amino Acid Derivatives –
`Potent New Agents for the Treatment of Epilepsy: Synthesis,
`and Spectroscopic and Pharmacological Properties (May
`1986)
`
`Harold Kohn & Judith D. Conley, New Antiepileptic Agents,
`24 Chemistry in Britain 231 (March 1988)
`
`European Patent Application No. 0 194 464
`(“’464 application”)
`
`Harold Kohn et al., Marked Stereospecificity in a New Class
`of Anticonvulsants, 457 Brain Res. 371 (1988)
`
`Harold Kohn et al., Preparation and Anticonvulsant Activity
`of a Series of Functionalized α-Aromatic and α-
`Heteroaromatic Amino Acids, 33 J. Med. Chem. 919 (1990)
`
`European Patent Application No. 0 263 506
`(“’506 application”)
`
`European Patent Application No. 0 400 440
`(“’440 application”)
`
`Harold Kohn et al., Synthesis and Anticonvulsant Activities
`of α-Heterocyclic α-Acetamido-N-Benzylacetamide
`Derivatives, 36 J. Med. Chem. 3350 (1993)
`
`Harold Kohn et al., Anticonvulsant Properties of N-
`Substituted α,α-Diamino Acid Derivatives, 83 J.
`Pharmaceutical Sci. 689 (May 1994)
`
`C.W. Thornber, Isosterism and Molecular Modification in
`Drug Design, 8 Chemical Soc’y Revs. 563 (1979)
`
`3
`
`

`
`
`
`Exhibit
`
`Description
`
`(“Thornber 1979”)
`
`1028
`
`1029
`
`1030
`
`1031
`
`
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`Wilson & Gisvold’s Textbook of Organic Medicinal and
`Pharmaceutical Chemistry, Ch. 2 (Delgado & Remers eds.
`1991) (“W&G 1991”)
`
`Richard B. Silverman, The Organic Chemistry of Drug
`Design and Drug Action, Ch. 2 (1992) (“Silverman 1992”)
`
`Rosa Amoroso et al., A New Route to the Synthesis of Amino
`Acids Through the Mercury Cyclization of Chiral Amidals,
`57 J. Org. Chem. 1082 (1992)
`
`S. Cerrini et al., Serine-Containing 10-Membered
`Cyclodepsipeptides, 41 Int’l J. Peptide Protein Res. 282
`(1993)
`
`Svante Axelsson et al., Versatile Synthesis of
`Stereospecifically Labelled D-Amino Acids via Labelled
`Aziridines, J. Chem. Soc. Perkin Trans. 1 (1994)
`
`Oliver Keil et al., New Hydantoinases from Thermophilic
`Microorganisms – Synthesis of Enantiomerically Pure D-
`Amino Acids, 6 Tetrahedron: Asymmetry 1257 (1995)
`
`Patrick Bardel et al., Synthesis and Anticonvulsant Activities
`of α-Acetamido-N-Benzylacetamide Derivatives Containing
`an Electron-Deficient α-Heteroaromatic Substituent, 37 J.
`Med. Chem. 4567 (1994)
`
`FDA, Guideline for Industry: Dose-Response Information to
`Support Drug Registration (Nov. 1994)
`
`R. Schmidt, Dose-Finding Studies in Clinical Drug
`Development, 34 Eur. J. Clin. Pharmacol. 15-19 (1988)
`
`Declaration of James F. Hurst in Support of Motion for Pro
`Hac Vice Admission
`
`4
`
`

`
`Description
`
`Declaration of Charles B. Klein in Support of Motion for
`Pro Hac Vice Admission
`
`Declaration of Maureen L. Rurka in Support of Motion for
`Pro Hac Vice Admission
`
`
`
`Exhibit
`
`1038
`
`1039
`
`
`
`Respectfully submitted,
`
`
`
` /Samuel S. Park/
`Samuel S. Park
`Reg. No. 59,656
`Lead Counsel for Petitioners Actavis,
`Inc., Actavis Laboratories FL, Inc.,
`Actavis Pharma, Inc., Amneal
`Pharmaceuticals, LLC, Amneal
`Pharmaceuticals of New York, LLC,
`Aurobindo Pharma Ltd., Aurobindo
`Pharma USA, Inc., Breckenridge
`Pharmaceutical, Inc., Vennoot
`Pharmaceuticals, LLC, Sandoz Inc.,
`Sun Pharma Global FZE, and Sun
`Pharmaceutical Industries, Ltd.
`
`Dated: August 19, 2014
`
`
`
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`Telephone: (312) 558-7931
`Fax: (312) 558-5700
`Email: spark@winston.com
`
`
`5
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.105(a), I certify that, on August 19,
`
`2014, I caused to be served true and correct copies of the foregoing
`
`“PETITIONERS’ EXHIBIT LIST (as of August 19, 2014)” by electronic mail on
`
`the following attorneys:
`
`
`
`Andrea G. Reister (Reg. No. 36,253)
`COVINGTON & BURLING LLP
`1201 Pennsylvania Ave., NW
`Washington, DC 20004
`areister@cov.com
`
`Lead Counsel for Patent Owner
`
`Enrique D. Longton (Reg. No. 47,304)
`Gregory S. Discher (Reg No. 42,488)
`COVINGTON & BURLING LLP
`1201 Pennsylvania Ave., NW
`Washington, DC 20004
`rlongton@cov.com
`gidscher@cov.com
`
`Backup Counsel for Patent Owner
`
`Respectfully submitted,
`
` /Samuel S. Park/
`Samuel S. Park
`Reg. No. 59,656
`
`Lead Counsel for Petitioners
`
`
`
`
`
`Dated: August 19, 2014
`
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`Telephone: (312) 558-7931
`Fax: (312) 558-5700
`Email: spark@winston.com

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket